4D Molecular Therapeutics... (FDMT)
NASDAQ: FDMT
· Real-Time Price · USD
7.28
0.18 (2.54%)
At close: Aug 15, 2025, 3:59 PM
7.16
-1.58%
After-hours: Aug 15, 2025, 06:53 PM EDT
4D Molecular Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 15K | 14K | 1K | 3K | 5K | 28K | -19K | 20.2M | 239K | 298K | 1.25M | 500K | 162K | 1.22M | 92K | 1.37M | 14.58M | 2M |
Cost of Revenue | 1.89M | n/a | 1.78M | 1.7M | 1.62M | 1.59M | 4.24M | 1.4M | 1.43M | 1.41M | 1.39M | 879K | 831K | 782K | 1.89M | 15.84M | 15.22M | 12.77M |
Gross Profit | -1.87M | 14K | -1.78M | 3K | -1.62M | -1.57M | -4.25M | 18.81M | -1.19M | -1.11M | -141K | -379K | -669K | 437K | -1.79M | -14.47M | -643K | -10.77M |
Operating Income | -59.46M | -53.62M | -56.12M | -51.13M | -42.46M | -38.14M | -36.65M | -13.97M | -32.14M | -30.11M | -28.72M | -26.5M | -28.43M | -26.39M | -24.76M | -22.66M | -7.6M | -16.31M |
Interest Income | 4.86M | 5.58M | 6.47M | 7.29M | 7.55M | 5.75M | 4.38M | 3.88M | 2.51M | 1.44M | 1.34M | 795K | 340K | 100K | n/a | 435K | 7K | 7K |
Pretax Income | -54.66M | -47.97M | -49.67M | -43.84M | -34.95M | -32.4M | -32.28M | -10.26M | -29.62M | -28.68M | -27.38M | -25.69M | -28.09M | -26.34M | -25.08M | -22.24M | -7.59M | -16.41M |
Net Income | -54.66M | -47.97M | -49.67M | -43.84M | -34.95M | -32.4M | -32.28M | -10.26M | -29.62M | -27.26M | -27.27M | -24.09M | -27.41M | -26.18M | -25.08M | -22.24M | -7.59M | -16.41M |
Selling & General & Admin | 11.52M | 12.94M | 14.63M | 12.65M | 10.6M | 8.7M | 10.61M | 9.11M | 8.79M | 7.99M | 8.47M | 8.05M | 8.17M | 8.23M | 7.33M | 8.19M | 6.95M | 5.54M |
Research & Development | 47.95M | 40.7M | 43.09M | 38.48M | 31.86M | 27.87M | 26.03M | 25.07M | 23.58M | 22.41M | 21.5M | 18.94M | 20.42M | 19.38M | 17.53M | 15.84M | 15.22M | 12.77M |
Other Expenses | n/a | n/a | -3.38M | n/a | n/a | -10K | -11K | -158K | 2.52M | 1.42M | 3K | 9K | n/a | -46K | -7K | -13K | n/a | -101K |
Operating Expenses | 59.47M | 53.63M | 54.33M | 51.13M | 42.46M | 36.57M | 36.63M | 34.18M | 32.38M | 30.4M | 29.97M | 27M | 28.59M | 27.61M | 24.86M | 24.03M | 22.18M | 18.31M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 1.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | 1.59M | n/a | n/a | -1.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 59.47M | 53.63M | 56.12M | 51.13M | 42.46M | 38.16M | 36.63M | 34.18M | 32.38M | 30.4M | 29.97M | 27M | 28.59M | 27.61M | 24.86M | 24.03M | 22.18M | 18.31M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.42M | -106K | -1.6M | -680K | -154K | n/a | n/a | n/a | -7K |
Shares Outstanding (Basic) | 55.93M | 55.74M | 53.94M | 55.55M | 55.28M | 49.27M | 39.13M | 42.26M | 38.34M | 32.72M | 32.49M | 32.39M | 32.28M | 32.23M | 27.02M | 27.02M | 26.74M | 26.69M |
Shares Outstanding (Diluted) | 55.93M | 55.74M | 53.94M | 55.55M | 55.28M | 49.27M | 39.13M | 42.26M | 38.34M | 32.72M | 32.49M | 32.39M | 32.32M | 32.23M | 27.02M | 27.02M | 26.74M | 26.69M |
EPS (Basic) | -0.98 | -0.86 | -0.9 | -0.79 | -0.63 | -0.66 | -0.83 | -0.24 | -0.77 | -0.83 | -0.84 | -0.74 | -0.85 | -0.81 | -0.93 | -0.82 | -0.28 | -0.61 |
EPS (Diluted) | -0.98 | -0.86 | -0.9 | -0.79 | -0.63 | -0.66 | -0.83 | -0.24 | -0.77 | -0.83 | -0.84 | -0.74 | -0.85 | -0.81 | -0.93 | -0.82 | -0.28 | -0.61 |
EBITDA | -59.46M | -51.87M | -61.04M | -49.43M | -40.83M | -36.54M | -35.14M | -12.58M | -30.71M | -28.69M | -27.33M | -25.62M | -27.59M | -25.61M | -22.88M | -22.28M | -7.23M | -15.93M |
EBIT | -54.66M | -53.62M | -56.12M | -51.13M | -42.46M | -38.14M | -36.65M | -13.97M | -32.14M | -30.11M | -28.72M | -26.5M | -28.43M | -26.39M | -24.76M | -22.66M | -7.6M | -16.31M |
Depreciation & Amortization | 1.89M | 1.75M | -4.92M | 1.7M | 1.62M | 1.59M | 1.51M | 1.4M | 1.43M | 1.41M | 1.39M | 879K | 831K | 782K | 1.89M | 382K | 370K | 381K |